Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125175363 | 12517536 | 3 | F | 201403 | 20160926 | 20160630 | 20160929 | EXP | US-PERRIGO-16US017435 | PERRIGO | 65.14 | YR | M | Y | 81.63000 | KG | 20160929 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125175363 | 12517536 | 1 | PS | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | Intramuscular | 1/4 ML, WEEKLY | Y | UNKNOWN | 40530 | SOLUTION FOR INJECTION | |||||||
| 125175363 | 12517536 | 2 | SS | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | Intramuscular | 1/2 ML, WEEKLY | Y | UNKNOWN | 40530 | SOLUTION FOR INJECTION | |||||||
| 125175363 | 12517536 | 3 | SS | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | Intramuscular | 1/4 ML, WEEKLY | Y | 152094.1 | 0 | ||||||||
| 125175363 | 12517536 | 4 | SS | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | Intramuscular | 1/2 ML, WEEKLY | Y | 152094.1 | 0 | ||||||||
| 125175363 | 12517536 | 5 | SS | DEPO-TESTOSTERONE | TESTOSTERONE CYPIONATE | 1 | Unknown | UNK | Y | UNKNOWN | 0 | ||||||||
| 125175363 | 12517536 | 6 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | 300 UNK,DAILY | D | UNKNOWN | 0 | ||||||||
| 125175363 | 12517536 | 7 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 250 MG, QD | D | UNKNOWN | 0 | 250 | MG | QD | |||||
| 125175363 | 12517536 | 8 | C | MULTIVITAMIN /07504101/ | VITAMINS | 1 | Oral | UNK | D | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125175363 | 12517536 | 1 | Blood testosterone decreased |
| 125175363 | 12517536 | 3 | Blood testosterone decreased |
| 125175363 | 12517536 | 5 | Product used for unknown indication |
| 125175363 | 12517536 | 6 | Product used for unknown indication |
| 125175363 | 12517536 | 7 | Product used for unknown indication |
| 125175363 | 12517536 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125175363 | 12517536 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125175363 | 12517536 | Deep vein thrombosis | |
| 125175363 | 12517536 | Drug administered at inappropriate site | |
| 125175363 | 12517536 | Dyspnoea | |
| 125175363 | 12517536 | Oestradiol increased | |
| 125175363 | 12517536 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125175363 | 12517536 | 1 | 2015 | 0 | ||
| 125175363 | 12517536 | 3 | 2015 | 0 | ||
| 125175363 | 12517536 | 4 | 20160525 | 0 | ||
| 125175363 | 12517536 | 5 | 20160122 | 20160608 | 0 |